October 01, 2014 2:20 PM ET

Pharmaceuticals

Company Overview of Semafore Pharmaceuticals, Inc.

Executive Profile

Daniel F. Hoth M.D.

Acting Chief Medical Officer, Semafore Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 10 different industries.

See Board Relationships
68--

Background

Dr. Daniel F. Hoth, M.D., serves as an Acting Chief Medical Officer of Semafore Pharmaceuticals, Inc. Dr. Hoth serves as the President of Hoth Consulting, where he provides drug development and clinical trial consulting services to pharmaceutical and biotechnology companies. He serves as clinical and drug development veteran with more than 25 years of experience. Dr. Hoth served as the Senior Vice President and Chief Medical Officer at AXYS Pharmaceuticals, Inc., from ...

Corporate Headquarters

8496 Georgetown Road
Indianapolis, Indiana 46268

United States

Phone: 317-876-3075
Fax: 317-876-3272

Board Members Memberships

Director, Chairman of Corporate Governance and Nominating Committee, Chairman of Research and Development Committee and Member of Compensation Committee
Director and Member of Compensation Committee
Director
2006-2010
Former Director

Education

BA
Franklin & Marshall College
MD
Georgetown University School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Semafore Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.